أخبار
New arthritis drug to get priority review by FDA.
| العنوان: | New arthritis drug to get priority review by FDA. |
|---|---|
| المصدر: | Wall Street Journal - Eastern Edition. 08/25/98, Vol. 232 Issue 39, pA8. 0p. |
| مصطلحات موضوعية: | TREATMENT of arthritis |
| الشركة/الكيان: | MONSANTO Co. 845614283 MON, UNITED States. Food & Drug Administration |
| مستخلص: | Reports that the arthritis drug, Celebra by the Saint Louis, Missouri-based Monsanto Company, will take priority when the United States Food and Drug Administration conducts its review. Increase of Monsanto and its agreed-to acquirer, American Home Products Corporation's shares to the news; Views of analysts that the drug could generate $2 billion or more in annual sales. |
| قاعدة البيانات: | Business Source Index |
Full Text Finder | تدمد: | 00999660 |
|---|